CVE-2022-38351 — HIGH (8.8)

Vulnerability Description

A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.

CVSS Score

8.8

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

HIGH

Availability

HIGH

Affected Products

Vendor	Product	Versions
Supremainc	Biostar 2	2.8.16

Related Weaknesses (CWE)

CWE-269

References

https://nobugescapes.com/blog/privilege-escalation-from-user-operator-to-system-ExploitThird Party Advisory
https://nobugescapes.com/wp-content/uploads/2022/08/Part1.docxExploitThird Party Advisory
https://nobugescapes.com/blog/privilege-escalation-from-user-operator-to-system-ExploitThird Party Advisory
https://nobugescapes.com/wp-content/uploads/2022/08/Part1.docxExploitThird Party Advisory

FAQ

What is CVE-2022-38351?

CVE-2022-38351 is a vulnerability with a CVSS score of 8.8 (HIGH). A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.

How severe is CVE-2022-38351?

CVE-2022-38351 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-38351?

Check the references section above for vendor advisories and patch information. Affected products include: Supremainc Biostar 2.